المؤلفون: National Cancer Institute (NCI)

المصدر: Phase II Open-Label Multi-Cohort Study Evaluating CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Patients With Advanced Chemorefractory Colorectal, Pancreatic, or Other Solid Cancers

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05733000Test

المصدر: Phase 1 Trial of Gemcitabine Combined With the Elimusertib (BAY 1895344) ATR Inhibitor With Expansion Cohorts in Advanced Pancreatic and Ovarian Cancer

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04616534Test

المصدر: A Phase 1 Trial of the ATR Inhibitor BAY 1895344 in Combination With Cisplatin and With Cisplatin Plus Gemcitabine in Advanced Solid Tumors With an Emphasis on Urothelial Carcinoma

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04491942Test

المصدر: A Phase 1b Combination Study of INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105)

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03920839Test

المؤلفون: Takeda

المصدر: Fuchs CS, Azevedo S, Okusaka T, Van Laethem JL, Lton LR, Rss H, Szczyl C, Moore MJ, Peeters M, Bodoky G, eda M, Melhar B, Nemecek R, Ohkawa S, Swboda-Sadlej A, Tjuland SA, Van Cutsem E, Loberg R, Haddad V, Gansert JL, Bach BA, Carrato A. A phase 3 randomed, double-bld, placebo-controlled trl of ganumab or placebo combatn wh gemcabe as fst-le therapy for metastat adenocarcoma of the pancreas: the GAMMA trl. Ann Oncol. 2015 May;26(5):921-927. do 10.1093/annonc/mdv027. Epub 2015 Jan 21.
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Trial of AMG 479 or Placebo in Combination With Gemcitabine as First Line Therapy for Metastatic Adenocarcinoma of the Pancreas

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT01231347Test

Other URLs: http://www.amgentrials.comTest

المؤلفون: Oregon Health and Science University

المساهمون: Charles D Lopez, Principal Investigator

المصدر: An Open-Label, Phase II Trial to Assess Efficacy and Safety of Onvansertib in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Previously Untreated, Locally-Advanced or Unresectable Pancreatic Adenocarcinoma

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06398587Test

المساهمون: John Lenehan, Principal Investigator

المصدر: An Open-label, Single-arm, Phase 1 Study of the Combination of FMT and Gemcitabine With Nab-paclitaxel as First-line Therapy in Patients With Advanced Pancreatic Ductal Adenocarcinoma.

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06393400Test

المصدر: Brightline-3: A Phase III, Randomized, Open-label, Multi-center Trial of Brigimadlin + Ezabenlimab Compared to Gemcitabine + Docetaxel for Second-line Treatment of Patients With Advanced TP53 Wild-type Soft Tissue Sarcoma Subtypes

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06370871Test

Other URLs: http://www.mystudywindow.comTest

المصدر: A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 193 in Combination With Other Therapies in Subjects With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous MTAP-deletion

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06360354Test

Other URLs: http://www.amgentrials.comTest

المصدر: A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of TQB2930 for Injection Monotherapy or in Combination for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Recurrent / Metastatic Breast Cancer

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06202261Test